physalaemin [6342]



physalaemin


SMILES CSCCC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCCN)NC(=O)C(CC(N)=O)NC(=O)C1CCCN1C(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C1CCC(=O)N1)C(N)=O
InChIKey SHSUJLMLURFKID-UHFFFAOYSA-N
Sequence XADPNKFYGLM
HELM PEPTIDE1{[*C(=O)C1CCC(=O)N1 |$_R2;;;;;;;;$|].(A,[dA]).(D,[dD]).(P,[dP]).(N,[dN]).(K,[dK]).(F,[dF]).(Y,[dY]).G.(L,[dL]).(M,[dM]).[am]}$$$$V2.0

Chemical Properties

Hydrogen bond acceptors 17
Hydrogen bond donors 15
Rotatable bonds 37
Log P -3.775
Molecular weight (Da) 1264.6
Stereochemistry info unspecified


No bioactivity data available.

physalaemin


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) NK1


Compound is not listed as a drug.